Plasma protein fraction. Product improvement studies.
The vasodilative effects associated with the use of sodium acetate have been reported in the literature. Preparations of plasma protein fraction (PPF) substantially free of this vasodilator were developed. This paper presents and discusses experimental work on the improved product.
D000085:Acetates; D000818:Animals; D001798:Blood Proteins / Q000009:adverse effects; D001920:Bradykinin; D005591:Chemical Fractionation; D004285:Dogs; D005174:Factor XII; D015956:Factor XIIa; D006801:Humans; D010446:Peptide Fragments; D051381:Rats; D065227:Transfusion Reaction; D014665:Vasodilator Agents / Q000494:pharmacology
D000085:Acetates; D001798:Blood Proteins; D010446:Peptide Fragments; D014665:Vasodilator Agents; D005174:Factor XII; D015956:Factor XIIa; D001920:Bradykinin